Publications 2008
Rácz I, Bilkei-Gorzo A, Markert A, Stamer F, Göthert M, Zimmer A. (2008). Anandamide effects on 5-HT(3) receptors in vivo. Eur J Pharmacol., 596(1-3): 98-101.
Moreira FA, Kaiser N, Monory K, Lutz B (2008) Reduced anxiety-like behaviour induced by genetic and pharmacological inhibition of the endocannabinoid-degrading enzyme fatty acid amide hydrolase (FAAH) is mediated by CB1 receptors. Neuropharmacology 54:141-50.
Moreira FA, Lutz B. (2008). The endocannabinoid system: emotion, learning and addiction. Addict Biol, 13(2):196-212
Huge V, Lauchart M, Förderreuther S, Kaufhold W, Valet M, Azad SC, Beyer A, Magerl W (2008) Interaction of hyperalgesia and sensory loss in complex regional pain syndrome type I (CRPS I). PLoS One 3:e2742
Gertsch J, Leonti M, Raduner S, Racz I, Chen JZ, Xie XQ, Altmann KH, Karsak M, Zimmer A. (2008). Beta-carophyllene is a diatary cannabinoid. Proc. Natl. Acad. Sci. USA, 26: 9099-9104.
Racz I, Nadal X, Alferink J, Banos JE, Rehnelt J, Martin M, Pintado B, Gutierrez-Adan A, Sanguino E, Manzanares J, Zimmer A#, Maldonado R#. (2008). Crucial role of CB2 cannabinoid receptor in the regulation of central immune responses during neuropathic pain. J.Neurosci., 28: 12125-12135. #corresponding author.
Racz I, Nadal X, Alferink J, Banos JE, Rehnelt J, Martin JM, Pintado B, Gutierrez-Adan A, Sanguino E, Manzanares J, Bellora N, Zimmer A#, Maldonado R#. (2008). Interferon-gamma is a critical modulator of CB2 cannabinoid receptor signaling during neuropathic pain. J.Neurosci., 28: 12136-12145. #corresponding author.